Epigenetic markers correlate with allergic rhinitis severity

August 4, 2017

(HealthDay)—Participants with grass pollen-induced allergic rhinitis undergo epigenetic changes within three hours of exposure to grass pollen, according to a study published online July 29 in Allergy.

Michelle L. North, Ph.D., from Queen's University in Kingston, Canada, and colleagues examined genome-wide among 38 allergy suffers and eight controls exposed to grass pollen for three hours on two consecutive days. The Infinium Methylation 450K array assessed DNA methylation at baseline and at three hours in peripheral blood.

The researchers found that there were 42 sites that showed significant DNA methylation changes of ≥2 percent. Pyrosequencing validated DNA methylation changes in tryptase gamma 1 (TPSG1), schlafen 12 (SLFN12), and mucin 4 (MUC4) in response to exposure. Symptoms significantly correlated with SLFN12 DNA methylation (P < 0.05), and the baseline DNA methylation pattern was predictive of symptom severity upon grass allergen exposure (P < 0.05). In a separate validation cohort, changes in MUC4 DNA methylation in nasal brushings correlated with drop in peak nasal inspiratory flow (P = 0.034), and MUC4 gene expression was significantly increased (P < 0.0001).

"In conclusion, this study demonstrated that participants with grass undergo epigenetic changes within three hours upon exposure to ," the authors write. "This study also highlights the possibility that epigenetic changes in the blood may be indicative of similar modifications in target tissues, and that preexisting , potentially due to environmental exposures, may have effects on subsequent responses to allergen."

One author disclosed financial ties to the pharmaceutical industry.

Explore further: Booster allergen immunotx cuts symptoms in allergic rhinitis

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Booster allergen immunotx cuts symptoms in allergic rhinitis

July 14, 2017
(HealthDay)—For patients with grass pollen-induced allergic rhinitis (AR), booster allergen immunotherapy (AIT) using tyrosine-absorbed grass pollen allergoids containing the adjuvant monophosphoryl lipid A (MPL) prevents ...

Successful phase IIB trial with third-generation grass pollen allergy vaccine BM32

January 26, 2017
Biomay, a global leader in allergy immunotherapy, announced today that a second Phase IIb study (clinicaltrials.gov identifier NCT02643641) has been successfully completed with its third generation grass pollen allergy vaccine ...

DNA methylation in adulthood linked to season of birth

March 16, 2016
(HealthDay)—DNA methylation in adulthood is associated with season of birth and may influence the effect of season of birth on allergy, according to a study published online March 12 in Allergy.

Sublingual birch pollen preparation improves allergy

September 10, 2015
(HealthDay)—For adults with birch pollen-induced allergic rhinitis, a sublingual birch pollen preparation (SB) is associated with improvement in symptom scores versus placebo, according to a study published online Sept. ...

Study reveals using synthetic peptides could be a better solution for grass allergy sufferers

February 23, 2017
A new approach to treating grass allergies offers potential as a shorter and more effective alternative to traditional allergy shots, according to a recent study led by Queen's researcher Dr. Anne Ellis (Medicine, Biomedical ...

Get ready for spring - hay fever worse in spring than summer

December 21, 2011
Hay fever (runny nose, sneezing, itchy eyes) is caused by an allergy to pollen, and most commonly to grass pollen. These tiny grains bring misery to sufferers through spring and summer and pollen levels are often included ...

Recommended for you

A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder

September 21, 2018
In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic ...

Study shows surprise low-level ozone impact on asthma patients

September 21, 2018
A new study led by UNC School of Medicine researchers indicates that ozone has a greater impact on asthma patients than previously thought. The study, published in the Journal of Allergy and Clinical Immunology, recruited ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

Gut fungus exacerbates asthma in antibiotic-treated mice

September 20, 2018
A non-pathogenic fungus can expand in the intestines of antibiotic-treated mice and enhance the severity of allergic airways disease, according to a study published September 20 in the open-access journal PLOS Pathogens by ...

Paracetamol use in infancy is linked to increased risk of asthma in some teenagers

September 17, 2018
Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at ...

Cord blood clue to respiratory diseases

September 15, 2018
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.